Advertisement
Research ArticleArticle

Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A

Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
Drug Metabolism and Disposition July 1998, 26 (7) 631-639;

Article Information

vol. 26 no. 7 631-639
PubMed 
9660845
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 4, 1997
  • Accepted March 4, 1998
  • Published online July 1, 1998.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Richard L. Voorman,
  2. Stephen M. Maio,
  3. Michael J. Hauer,
  4. Philip E. Sanders,
  5. N. Ann Payne and
  6. Mark J. Ackland1
  1. Drug Metabolism Research, Pharmacia and Upjohn
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to December 2024

    AbstractFullPdf
    Aug 2017163
    Sep 20174126
    Oct 20172169
    Nov 20170189
    Dec 20170182
    Jan 20183201
    Feb 20181176
    Mar 20181120
    Apr 20182102
    May 20181183
    Jun 2018217015
    Jul 201802610
    Aug 20181141
    Sep 20180593
    Oct 20180174
    Nov 20180372
    Dec 20182061
    Jan 2019933
    Feb 2019521
    Mar 20191533
    Apr 2019700
    May 20191632
    Jun 20191012
    Jul 20191700
    Aug 20191411
    Oct 20191300
    Nov 20192500
    Dec 20191751
    Jan 20201400
    Feb 2020721
    Mar 20201142
    May 20201100
    Jun 20201000
    Jul 20201513
    Aug 2020413
    Sep 20201912
    Oct 2020210
    Nov 2020820
    Dec 20203400
    Jan 2021792
    Feb 20211050
    Mar 2021832
    Apr 20211432
    May 20215653
    Jun 2021941
    Jul 20212610
    Aug 20211731
    Sep 2021520
    Oct 2021710
    Nov 20212820
    Dec 20211520
    Jan 2022730
    Feb 2022121
    Mar 2022710
    Apr 2022970
    May 20222032
    Jun 20221351
    Jul 20222810
    Aug 20221221
    Sep 20221710
    Oct 20221730
    Nov 20221810
    Dec 20221210
    Jan 20231020
    Feb 2023411
    Mar 2023921
    Apr 20231610
    May 20232120
    Jun 2023810
    Jul 20231951
    Aug 20231550
    Sep 2023730
    Oct 2023910
    Nov 20231451
    Dec 20232880
    Jan 2024821
    Feb 2024940
    Mar 20241420
    Apr 2024580
    May 20241210
    Jun 20242530
    Jul 20243741
    Aug 20242201
    Sep 20241731
    Oct 20241820
    Nov 20241421
    Dec 2024700

    Back to top

    In this issue

    Download PDF
    Article Alerts
    Email Article
    Citation Tools

    Research ArticleArticle

    Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A

    Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
    Drug Metabolism and Disposition July 1, 1998, 26 (7) 631-639;
    Twitter logo Facebook logo Mendeley logo

    Jump to section

    Advertisement